Statistics for A valuation of the pharmaceutical company Novartis AG
Total visits
views | |
---|---|
A valuation of the pharmaceutical company Novartis AG | 572 |
Total visits per month
views | |
---|---|
December 2024 | 20 |
January 2025 | 4 |
February 2025 | 2 |
March 2025 | 3 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 0 |
File Visits
views | |
---|---|
Equity Valuation- A valuation of the pharmaceutical company Novartis AG.pdf(legacy) | 1045 |
Equity Valuation- A valuation of the pharmaceutical company Novartis AG.pdf | 33 |
90386025.pdf(legacy) | 1 |
9303.pdf(legacy) | 1 |
null(legacy) | 1 |
V0250102-365-390.pdf(legacy) | 1 |
203015363.pdf(legacy) | 1 |
Top country views
views | |
---|---|
United Kingdom | 92 |
United States | 68 |
Portugal | 46 |
Ireland | 37 |
China | 24 |
India | 22 |
Switzerland | 19 |
Germany | 18 |
Australia | 15 |
Italy | 15 |
Egypt | 14 |
Hungary | 13 |
Turkey | 11 |
Malaysia | 10 |
Brazil | 9 |
France | 9 |
Pakistan | 8 |
United Arab Emirates | 7 |
Canada | 7 |
Spain | 7 |
Belgium | 6 |
Hong Kong SAR China | 6 |
Nigeria | 6 |
Vietnam | 6 |
Austria | 5 |
Indonesia | 5 |
Netherlands | 5 |
Russia | 5 |
South Korea | 4 |
Sweden | 4 |
Slovenia | 4 |
Israel | 3 |
Philippines | 3 |
Ukraine | 3 |
Albania | 2 |
Bulgaria | 2 |
Denmark | 2 |
Greece | 2 |
Japan | 2 |
Kenya | 2 |
Namibia | 2 |
New Zealand | 2 |
Serbia | 2 |
Trinidad & Tobago | 2 |
Andorra | 1 |
Bosnia & Herzegovina | 1 |
Bangladesh | 1 |
Belarus | 1 |
Finland | 1 |
Iran | 1 |
Jordan | 1 |
St. Lucia | 1 |
Sri Lanka | 1 |
Lithuania | 1 |
Mauritius | 1 |
Oman | 1 |
Panama | 1 |
Poland | 1 |
Romania | 1 |
Saudi Arabia | 1 |
Singapore | 1 |
Slovakia | 1 |
Thailand | 1 |
Taiwan | 1 |
Tanzania | 1 |
Zambia | 1 |
Top city views
views | |
---|---|
Roanoke | 6 |
Dublin | 5 |
Barcelona | 2 |
Birkenhead | 1 |
Cariacica | 1 |
Dong-gu | 1 |
Gijón | 1 |
Penicuik | 1 |
Portlaoise | 1 |